Locoregional Therapy of Hepatocellular Carcinoma

Ali Habib; Kush Desai; Ryan Hickey; Bartley Thornburg; Robert Lewandowski; Riad Salem

doi:10.1016/j.cld.2015.01.008

Locoregional Therapy of Hepatocellular Carcinoma

Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem^*

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Review article › peer-review

28 Scopus citations

Abstract

Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

Original language	English (US)
Pages (from-to)	401-420
Number of pages	20
Journal	Clinics in liver disease
Volume	19
Issue number	2
DOIs	https://doi.org/10.1016/j.cld.2015.01.008
State	Published - May 1 2015

Keywords

Hepatocellular carcinoma
Interventional oncology
Locoregional therapies
Percutaneous ethanol injection
Radioembolization
Radiofrequency ablation
Transarterial chemoembolization
Transplantation

ASJC Scopus subject areas

Hepatology

Access to Document

10.1016/j.cld.2015.01.008

Cite this

@article{4cb3e707e4bf4b90bf478b773e2c7340,

title = "Locoregional Therapy of Hepatocellular Carcinoma",

abstract = "Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.",

keywords = "Hepatocellular carcinoma, Interventional oncology, Locoregional therapies, Percutaneous ethanol injection, Radioembolization, Radiofrequency ablation, Transarterial chemoembolization, Transplantation",

author = "Ali Habib and Kush Desai and Ryan Hickey and Bartley Thornburg and Robert Lewandowski and Riad Salem",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.cld.2015.01.008",

language = "English (US)",

volume = "19",

pages = "401--420",

journal = "Clinics in liver disease",

issn = "1089-3261",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Locoregional Therapy of Hepatocellular Carcinoma

AU - Habib, Ali

AU - Desai, Kush

AU - Hickey, Ryan

AU - Thornburg, Bartley

AU - Lewandowski, Robert

AU - Salem, Riad

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

AB - Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

KW - Hepatocellular carcinoma

KW - Interventional oncology

KW - Locoregional therapies

KW - Percutaneous ethanol injection

KW - Radioembolization

KW - Radiofrequency ablation

KW - Transarterial chemoembolization

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84928829356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928829356&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2015.01.008

DO - 10.1016/j.cld.2015.01.008

M3 - Review article

C2 - 25921670

AN - SCOPUS:84928829356

SN - 1089-3261

VL - 19

SP - 401

EP - 420

JO - Clinics in liver disease

JF - Clinics in liver disease

IS - 2

ER -

Locoregional Therapy of Hepatocellular Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this